Sudhir Saxena, Chief Technology Officer of GNQ Insilico, Inc. (GNQ), was invited by Deloitte Consulting to present GNQ’s multi-omics approach to personalized medicine through AI-powered digital twins at the Quantum Rising Conference held on December 14 and 15 in Atlanta, Georgia (hosted by the National Quantum Literacy Network). At the Quantum Rising conference, Saxena was a speaker on a panel that included Deloitte Consulting and IBM Quantum. He highlighted GNQ’s advanced human digital twins and the agentic AI-driven platform to enable precision medicine and democratize healthcare. He also elaborated on the possibilities of leveraging quantum computing in modeling whole-systems biology to further enhance the platform’s capabilities in personalizing medicine across diverse population segments.
GNQ’s presentation at the Quantum Rising Conference demonstrates GNQ’s commitment to advancing personalized medicine through cutting-edge technology. The current integration of agentic AI with digital twin technology, combined with strategic research into quantum computing applications, represents a comprehensive approach to advancing healthcare, offering new possibilities for personalized treatment approaches and drug development.